CN109943582A - Method for producing dopamine based on catalysis of dopamine decarboxylase - Google Patents

Method for producing dopamine based on catalysis of dopamine decarboxylase Download PDF

Info

Publication number
CN109943582A
CN109943582A CN201910257075.0A CN201910257075A CN109943582A CN 109943582 A CN109943582 A CN 109943582A CN 201910257075 A CN201910257075 A CN 201910257075A CN 109943582 A CN109943582 A CN 109943582A
Authority
CN
China
Prior art keywords
dopamine
ddc
pet28a
dopa
dop adecarboxylase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910257075.0A
Other languages
Chinese (zh)
Inventor
陈可泉
程莎莎
高思远
陆秋豪
许晟
王昕�
张阿磊
杨赛
李孟阳
欧阳平凯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Tech University
Original Assignee
Nanjing Tech University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Tech University filed Critical Nanjing Tech University
Priority to CN201910257075.0A priority Critical patent/CN109943582A/en
Publication of CN109943582A publication Critical patent/CN109943582A/en
Pending legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

本发明公开了一种基于多巴胺脱羧酶催化产多巴胺的方法,该方法具体包括以下步骤:构建表达多巴脱羧酶(DDC)的基因工程菌BL21(DE3)/pET28a‑DDC;培养基因工程菌BL21(DE3)/pET28a‑DDC并诱导表达DDC;收集上述菌体,用缓冲液重悬菌体后,超声破碎,离心去除杂质,得DDC的粗酶液;以多巴为底物,加入0.1‑1mM磷酸吡哆醛后调节反应体系的pH,加入DDC粗酶液反应得产物多巴胺。本发明方法是首次系统的做出从多巴到多巴胺的酶催化生产工艺,催化效率高达7.4g/l,转化率高达95%以上,环境友好,原料易得,生产成本低,工艺简单,反应条件温和,具有很好的工业化生产前景。

The invention discloses a method for producing dopamine catalyzed by dopamine decarboxylase. The method specifically comprises the following steps: constructing a genetically engineered bacterium BL21 (DE3)/pET28a-DDC expressing dopa decarboxylase (DDC); culturing the genetically engineered bacterium BL21 (DE3)/pET28a-DDC and induced expression of DDC; collect the above-mentioned cells, resuspend the cells with buffer, sonicate, and centrifuge to remove impurities to obtain the crude enzyme liquid of DDC; using dopa as the substrate, add 0.1- After adjusting the pH of the reaction system with 1 mM pyridoxal phosphate, the DDC crude enzyme solution was added to react to obtain the product dopamine. The method of the invention is the first systematically made an enzyme catalysis production process from dopa to dopamine, the catalytic efficiency is as high as 7.4g/l, the conversion rate is as high as 95% or more, the environment is friendly, the raw materials are readily available, the production cost is low, the process is simple, and the reaction The conditions are mild and have good prospects for industrial production.

Description

一种基于多巴胺脱羧酶催化产多巴胺的方法A method for producing dopamine catalyzed by dopamine decarboxylase

技术领域technical field

本发明属于生物酶催化技术领域,尤其涉及一种基于多巴胺脱羧酶催化产多巴胺的方法。The invention belongs to the technical field of biological enzyme catalysis, in particular to a method for catalyzing dopamine production based on dopamine decarboxylase.

背景技术Background technique

多巴又称二羟苯丙氨酸,左旋多巴,由酪氨酸氧化产生的一种氨基酸,能通过血脑屏障,于体内转变为多巴胺。医疗上用于震颤麻痹症的治疗。Dopa, also known as dihydroxyphenylalanine, levodopa, is an amino acid produced by the oxidation of tyrosine, which can pass through the blood-brain barrier and be converted into dopamine in the body. Medically used for the treatment of tremor paralysis.

多巴胺为多巴胺受体激动药。多巴胺是脑内一种重要的神经递质,多巴胺能系统与神经精神性疾病密切相关,多巴胺是人体能自行合成的物质、有增强心肌收缩、增加心排血量、升高动脉血压、抗休克作用。由于它的突出生理功能,多巴胺人工合成的成功,使它成为抗休克的合成药物。经临床应用表明,多巴胺对于不同类型的休克均有显著疗效。为当今治疗帕金森病,药物依赖和精神分裂症等中枢神经疾病的药物开发,有着重要的理论研究意义和应用前景。多巴胺的合成难度大,成本高,对产品的纯度要求高,产量较少。因此,提供一种可以有效经济产生多巴胺是非常必要的。Dopamine is a dopamine receptor agonist. Dopamine is an important neurotransmitter in the brain. The dopaminergic system is closely related to neuropsychiatric diseases. Dopamine is a substance that the human body can synthesize by itself. It can enhance myocardial contraction, increase cardiac output, increase arterial blood pressure, and resist shock. effect. Due to its prominent physiological function, the success of dopamine artificial synthesis makes it an anti-shock synthetic drug. Clinical application shows that dopamine has a significant effect on different types of shock. It has important theoretical research significance and application prospects for the development of drugs for the treatment of Parkinson's disease, drug dependence and schizophrenia. The synthesis of dopamine is difficult, expensive, requires high purity of the product, and yields less. Therefore, it is very necessary to provide a method that can efficiently and economically produce dopamine.

现有技术生产多巴胺的方法,其中化工生产转化率低,成本高,污染严重,生物合成方法周期长,提取困难,本发明方法用的酶催化法,催化效率以及转化率高,环境友好,工业化前景好,是一种新型的酶催化方法。The method for producing dopamine in the prior art, wherein the chemical production conversion rate is low, the cost is high, the pollution is serious, the period of the biosynthesis method is long, and the extraction is difficult. It has good prospects and is a new type of enzyme catalysis method.

发明内容SUMMARY OF THE INVENTION

针对现有技术的不足,本发明的目的在于提供一种基于多巴胺脱羧酶催化产多巴胺的方法,该方法绿色环保,且与化学生产方法简单,成本低廉,适合产业化。In view of the deficiencies of the prior art, the purpose of the present invention is to provide a method for producing dopamine catalyzed by dopamine decarboxylase, which is green and environmentally friendly, and has the advantages of simple chemical production method, low cost and suitable for industrialization.

为解决现有技术问题,本发明采取的技术方案为:In order to solve the prior art problem, the technical scheme adopted in the present invention is:

一种基于多巴胺脱羧酶催化产多巴胺的方法,包括以下步骤:A method for producing dopamine based on dopamine decarboxylase catalysis, comprising the following steps:

步骤1,构建表达多巴脱羧酶的基因工程菌BL21(DE3)/pET28a-DDC;Step 1, construct genetically engineered bacteria BL21(DE3)/pET28a-DDC expressing dopa decarboxylase;

步骤2,培养多巴脱羧酶的基因工程菌BL21(DE3)/pET28a-DDC;Step 2, culturing dopa decarboxylase genetically engineered bacteria BL21(DE3)/pET28a-DDC;

步骤3,收集步骤2中的基因工程菌,用pH5-9的缓冲液重悬后,超声破碎仪破碎;离心去除杂质,得到多巴脱羧酶的粗酶液;Step 3, collecting the genetically engineered bacteria in step 2, resuspending with a pH 5-9 buffer, and crushing with an ultrasonic crusher; centrifuging to remove impurities to obtain a crude enzyme solution of dopa decarboxylase;

步骤4,选取多巴作为底物,加入0.1-1mM磷酸吡哆醛,再添加缓冲溶液调节反应体系的pH至5-9,最后加入多巴脱羧酶粗酶液0.5-2g/l,40-45℃反应0.5h-3h,得到产物多巴胺,反应体系中底物多巴的终浓度不超过6g/l。Step 4, select dopa as a substrate, add 0.1-1mM pyridoxal phosphate, then add a buffer solution to adjust the pH of the reaction system to 5-9, and finally add 0.5-2g/l of dopa decarboxylase crude enzyme solution, 40- Reaction at 45°C for 0.5h-3h to obtain the product dopamine, and the final concentration of the substrate dopa in the reaction system does not exceed 6g/l.

当反应结束后,可通过高效液相色谱法进行检测多巴胺。检测方法为Agilent1260 高效液相色谱;采用Agilent TC-C18色谱柱(150 mm×4.6 mm,5μm);以0.1%三氟乙酸溶液-乙腈(96:4)为流动相;流速1.0 ml·min-1;检测波长为280nm;柱温:室温。After the reaction, dopamine can be detected by high performance liquid chromatography. The detection method was Agilent1260 high performance liquid chromatography; Agilent TC-C18 column (150 mm×4.6 mm, 5 μm) was used; 0.1% trifluoroacetic acid solution-acetonitrile (96:4) was used as mobile phase; flow rate was 1.0 ml·min - 1 ; detection wavelength is 280nm; column temperature: room temperature.

作为改进的是,步骤1中所述构建表达多巴脱羧酶的基因工程菌的方法如下 :根据已报导的异色瓢虫来源多巴脱羧酶DDC的氨基酸序列(GenBank: AMQ13055.1)进行密码子优化后,全基因合成该序列,亚克隆到载体pET28a上,获得重组质粒pET28a-DDC,将构建好的重组质粒pET28a-DDC用氯化钙法转化进入大肠杆菌表达宿主BL21(DE3),得到多巴脱羧酶表达菌种BL21(DE3)/pET28a-DDC。As an improvement, the method for constructing a genetically engineered bacterium expressing dopa decarboxylase described in step 1 is as follows: coding is performed according to the reported amino acid sequence of dopa decarboxylase DDC (GenBank: AMQ13055.1). After suboptimization, the whole gene was synthesized and subcloned into the vector pET28a to obtain the recombinant plasmid pET28a-DDC. The constructed recombinant plasmid pET28a-DDC was transformed into the E. coli expression host BL21 (DE3) by the calcium chloride method to obtain Dopa decarboxylase expressing strain BL21(DE3)/pET28a-DDC.

作为改进的是,步骤2中基因工程菌BL21(DE3)/pET28a-DDC培养方法具体为:挑取表达多巴脱羧酶的基因工程菌BL21(DE3)/pET28a-DDC的单菌落,接种于LB培养基,37℃培养至OD值达到0.6以上,再加入0.5mM的IPTG,18℃培养10-12小时,离心收集表达多巴脱羧酶的基因工程菌BL21(DE3)/pET28a-DDC。As an improvement, the method for culturing genetically engineered bacteria BL21(DE3)/pET28a-DDC in step 2 is as follows: picking a single colony of genetically engineered bacteria BL21(DE3)/pET28a-DDC expressing dopa decarboxylase, inoculating it on LB culture medium at 37°C until the OD value reaches above 0.6, then add 0.5mM IPTG, culture at 18°C for 10-12 hours, and collect the genetically engineered bacteria BL21(DE3)/pET28a-DDC expressing dopa decarboxylase by centrifugation.

作为改进的是,步骤4中多巴的终浓度量为5g/l,磷酸吡哆醛的添加量为0.4mM,反应体系的pH为6.8-7.0,反应温度为42℃,添加多巴脱羧酶粗酶液浓度为1g/l,反应时间为1h。As an improvement, in step 4, the final concentration of dopa is 5g/l, the amount of pyridoxal phosphate added is 0.4mM, the pH of the reaction system is 6.8-7.0, the reaction temperature is 42°C, and dopa decarboxylase is added. The concentration of crude enzyme solution was 1g/l, and the reaction time was 1h.

进一步改进的是,步骤4中所述缓冲液为磷酸盐缓冲液、PBS缓冲液或Tris-盐酸缓冲液中一种。It is further improved that the buffer in step 4 is one of phosphate buffer, PBS buffer or Tris-hydrochloric acid buffer.

作为改进的是,步骤4中多巴作为底物,初始浓度为2g/l,分次加入反应体系,且终浓度不超过6g/l。As an improvement, dopa is used as the substrate in step 4, and the initial concentration is 2 g/l, which is added to the reaction system in stages, and the final concentration does not exceed 6 g/l.

作为改进的是,所述步骤3中超声破碎仪的功率为300W,破碎过程为间歇式破碎。As an improvement, in the step 3, the power of the ultrasonic crusher is 300W, and the crushing process is intermittent crushing.

有益效果:Beneficial effects:

与现有技术相比,化学工艺中时以香兰素为原料,先与硝基甲烷发生反应,生成的4-羟基-3-甲氧基-β-硝基乙苯(简称硝基物)。硝基物以锌加盐酸作还原剂进行还原反应,制得4-羟基-3-甲氧基乙胺盐(简称还原物),还原物经氢溴酸水解去甲基,再转化成盐酸盐即得多巴胺。在化学合成中,多巴胺的合成难度大,对产品的要求的纯度比较高,产量很小,存在着成本高,污染严重等缺点。本发明一种基于多巴胺脱羧酶催化产多巴胺的方法,在之前从未具体的研究过生物催化过程,本发明方法绿色安全,多巴胺的产量达到7.4g/l,转化率高达95%以上,本发明原料易得,生产成本低工艺简单,反应条件温和,催化效率以及转化率高,环境友好,工业化前景好,生产安全。Compared with the prior art, in the chemical process, vanillin is used as a raw material, which is first reacted with nitromethane to generate 4-hydroxy-3-methoxy-β-nitroethylbenzene (referred to as nitro) . The nitro compound is reduced with zinc and hydrochloric acid as a reducing agent to obtain 4-hydroxy-3-methoxyethylamine salt (reduced for short). The salt is dopamine. In chemical synthesis, the synthesis of dopamine is difficult, the purity required for the product is relatively high, the yield is small, and there are disadvantages such as high cost and serious pollution. The present invention is a method for producing dopamine catalyzed by dopamine decarboxylase. The biocatalytic process has never been specifically studied before. The method of the present invention is green and safe, the output of dopamine reaches 7.4 g/l, and the conversion rate is as high as more than 95%. The raw materials are readily available, the production cost is low, the process is simple, the reaction conditions are mild, the catalytic efficiency and the conversion rate are high, the environment is friendly, the industrialization prospect is good, and the production is safe.

附图说明Description of drawings

图1为实施例3中反应结束中产物的高效液相色谱图,其中,1-多巴胺标准品,2-多巴。Fig. 1 is the high performance liquid chromatogram of the product in the end of reaction in embodiment 3, wherein, 1-dopamine standard substance, 2-dopa.

具体实施方式Detailed ways

实施例1Example 1

构建表达多巴脱羧酶的基因工程菌BL21(DE3)/pET28a-DDCConstruction of genetically engineered bacteria BL21(DE3)/pET28a-DDC expressing dopa decarboxylase

根据已报导的异色瓢虫来源多巴脱羧酶DDC的氨基酸序列(GenBank: AMQ13055.1)进行密码子优化后(优化处理的步骤委托金斯瑞完成),全基因合成该序列,亚克隆到载体pET28a上,获得重组质粒pET28a-DDC,将构建好的重组质粒pET28a-DDC用氯化钙法转化进入大肠杆菌表达宿主BL21(DE3),得到多巴脱羧酶表达菌种BL21(DE3)/pET28a-DDC。According to the reported amino acid sequence of dopa decarboxylase DDC derived from Coccinella axyridis (GenBank: AMQ13055.1), after codon optimization (the optimization steps were entrusted to GenScript), the whole gene was synthesized and the sequence was subcloned into On the vector pET28a, the recombinant plasmid pET28a-DDC was obtained, and the constructed recombinant plasmid pET28a-DDC was transformed into the E. coli expression host BL21 (DE3) by the calcium chloride method to obtain the dopa decarboxylase expression strain BL21 (DE3)/pET28a -DDC.

实施例2Example 2

培养表达多巴脱羧酶的基因工程菌BL21(DE3)/pET28a-DDC,并诱导表达Culturing the genetically engineered bacteria BL21(DE3)/pET28a-DDC expressing dopa decarboxylase, and inducing the expression

挑取表达多巴脱羧酶的基因工程菌单菌落,接种于LB培养基,置于37℃培养;至OD值达到0.6,IPTG加入量为0.5mM,置于18℃-30℃培养10-12小时;揺瓶发酵结束后,离心收集表达多巴脱羧酶的基因工程菌,备用。将收集到的菌体用相应体积的缓冲液重悬起来,使用超声细胞破碎仪(破碎10min,超声2s,停3s,功率300W),破碎完成后,4000-8000rpm,4℃,离心8-10min获得多巴脱羧酶粗酶液,并用酶标仪测定蛋白浓度。Pick a single colony of genetically engineered bacteria expressing dopa decarboxylase, inoculate it in LB medium, and cultivate at 37 °C; when the OD value reaches 0.6, the amount of IPTG added is 0.5 mM, and culture at 18 °C-30 °C for 10-12 hours; after the fermentation in the bottle was completed, the genetically engineered bacteria expressing dopa decarboxylase were collected by centrifugation and used for later use. Resuspend the collected cells with the corresponding volume of buffer, and use an ultrasonic cell disrupter (10min for sonication, 2s for sonication, 3s for stop, 300W power), and after the fragmentation is completed, centrifuge at 4000-8000rpm, 4°C for 8-10min The dopa decarboxylase crude enzyme solution was obtained, and the protein concentration was determined with a microplate reader.

LB培养基的配方:10g/l蛋白胨,5g/l酵母粉,5g/l氯化钠。The formula of LB medium: 10g/l peptone, 5g/l yeast powder, 5g/l sodium chloride.

实施例3Example 3

催化产多巴胺,具体操作步骤为反应体系为10ml,取初始浓度为2g/l的多巴作为底物,加入0.4mM的PLP,用PBS缓冲液调节体系pH为6.8,再加入1g/l的粗酶浓度,40℃震荡反应,每10-15min补加底物多巴,每次1-3g/l,保证反应过程中终浓度不超过6g/l。反应结束后,利用高效液相色谱法(采用Agilent TC-C18色谱柱(150 mm×4.6 mm,5μm);以0.1%三氟乙酸溶液-乙腈(96:4)为流动相;流速1.0 ml·min-1;检测波长为280nm;柱温:室温)检测多巴胺的生成量。多巴胺的产量达到7.4g/l,转化率高达95%以上。To catalyze the production of dopamine, the specific operation steps are as follows: the reaction system is 10ml, the initial concentration of dopa is 2g/l as the substrate, 0.4mM of PLP is added, the pH of the system is adjusted to 6.8 with PBS buffer, and then 1g/l of crude oil is added. Enzyme concentration, shake reaction at 40°C, and add substrate dopa every 10-15min, 1-3g/l each time, to ensure that the final concentration during the reaction does not exceed 6g/l. After the reaction, high performance liquid chromatography (using Agilent TC-C18 column (150 mm×4.6 mm, 5 μm); 0.1% trifluoroacetic acid solution-acetonitrile (96:4) was used as the mobile phase; the flow rate was 1.0 ml· min-1; detection wavelength is 280 nm; column temperature: room temperature) to detect the amount of dopamine generated. The yield of dopamine reached 7.4g/l, and the conversion rate was as high as 95%.

实施例4Example 4

除粗酶液的添加量更改为0.5g/l外,其余同实施例3。反应结束后,通过高效液相色谱测得,多巴胺的产量达到7.0g/l,转化率达94%以上。Except that the addition amount of the crude enzyme solution was changed to 0.5 g/l, the rest were the same as in Example 3. After the reaction, as measured by high performance liquid chromatography, the output of dopamine reaches 7.0g/l, and the conversion rate reaches more than 94%.

实施例5Example 5

除反应体系的pH为8外,其余同实施例1。反应结束后,通过高效液相色谱检测,多巴胺的产量达到4.0g/l,转化率达89%以上。Except that the pH of the reaction system is 8, the rest are the same as in Example 1. After the completion of the reaction, as detected by high performance liquid chromatography, the output of dopamine reaches 4.0 g/l, and the conversion rate reaches more than 89%.

实施例6Example 6

以多巴为底物,采用步骤2培养的基因工程菌BL21(DE3)/pET28a-DDC直接催化生产多巴胺。除粗酶液更换为1g/l基因工程菌BL21(DE3)/pET28a-DDC外,其余同实施例1。反应结束后,通过高效液相色谱检测,多巴胺的产量0.5g/l。Using dopa as a substrate, the genetically engineered bacteria BL21(DE3)/pET28a-DDC cultivated in step 2 were used to directly catalyze the production of dopamine. Except that the crude enzyme solution was replaced with 1 g/l genetically engineered bacteria BL21(DE3)/pET28a-DDC, the rest were the same as in Example 1. After the reaction was completed, the yield of dopamine was 0.5 g/l as detected by high performance liquid chromatography.

实施例7Example 7

除底物多巴一次性添加进入反应体系,且初始浓度为5g/l时,其余同实施例1,反应结束后,通过高效液相色谱检测,多巴胺的产量达到5.0g/l,转化率达91%以上。Except that the substrate dopa was added into the reaction system at one time, and the initial concentration was 5 g/l, the rest were the same as in Example 1. After the reaction was completed, by high performance liquid chromatography detection, the output of dopamine reached 5.0 g/l, and the conversion rate reached 5.0 g/l. More than 91%.

实施例8Example 8

除不含PLP外,其余同实施例1,反应结束后,通过高效液相色谱检测,多巴胺的产量为0。Except not containing PLP, the rest are the same as in Example 1. After the reaction, the output of dopamine is 0 by high performance liquid chromatography detection.

从实施例3-8的结果可以看出,本发明反应体系在pH为6.8时,催化反应效率好,且PLP是反应体系中不可缺少的添加物。现有技术有化工方法和生物合成方法,化工方法转化率低,成本高,污染严重生物合成方法周期长,提取困难。与现有技术相比,本发明一种生物酶催化产生多巴胺的方法绿色环保,多巴胺的产量达到7.4g/l,转化率高达95%以上,本发明原料易得,生产成本低、工艺简单,反应条件温和,催化效率以及转化率高,环境友好,工业化前景好。It can be seen from the results of Examples 3-8 that when the pH of the reaction system of the present invention is 6.8, the catalytic reaction efficiency is good, and PLP is an indispensable additive in the reaction system. The prior art includes a chemical method and a biosynthesis method. The chemical method has low conversion rate, high cost, serious pollution, and the biosynthesis method has a long cycle and is difficult to extract. Compared with the prior art, the method for producing dopamine catalyzed by a biological enzyme of the present invention is environmentally friendly, the yield of dopamine reaches 7.4 g/l, the conversion rate is as high as 95% or more, the raw materials of the present invention are easily available, the production cost is low, and the process is simple, The reaction conditions are mild, the catalytic efficiency and conversion rate are high, the environment is friendly, and the industrialization prospect is good.

以上所述,仅为本发明较佳的具体实施方式,本发明的保护范围不限于此,任何熟悉本技术领域的技术人员在本发明披露的技术范围内,可显而易见地得到的技术方案的简单变化或等效替换均落入本发明的保护范围内。The above are only preferred specific embodiments of the present invention, and the protection scope of the present invention is not limited thereto. Any person skilled in the art can obviously obtain the simplicity of the technical solution within the technical scope disclosed in the present invention. Variations or equivalent substitutions fall within the protection scope of the present invention.

Claims (7)

1. a kind of method for producing dopamine based on dopamine decarboxylase enzymatic, which comprises the following steps:
Step 1, the genetic engineering bacterium BL21(DE3 of building expression DOP Adecarboxylase)/pET28a-DDC;
Step 2, the genetic engineering bacterium BL21(DE3 of DOP Adecarboxylase is cultivated)/pET28a-DDC;
Step 3, the genetic engineering bacterium in collection step 2, after being resuspended with the buffer of pH5-9, Ultrasonic Cell Disruptor is broken;Centrifugation is gone Except impurity, the crude enzyme liquid of DOP Adecarboxylase is obtained;
Step 4, DOPA is chosen as substrate, 0.1-1mM phosphopyridoxal pyridoxal phosphate is added, then is added buffer solution and adjusted reaction system PH to 5-9, is eventually adding DOP Adecarboxylase crude enzyme liquid 0.5-2g/l, and 40-45 DEG C of reaction 0.5h-3h obtains product dopamine, instead The final concentration of substrate DOPA in system is answered to be no more than 6g/l.
2. a kind of method for being catalyzed production dopamine based on DOP Adecarboxylase according to claim 1, which is characterized in that step The method of the genetic engineering bacterium of the DOP Adecarboxylase of building expression described in 1 is as follows: according to the harmonia axyridia source DOPA reported After the amino acid sequence (GenBank:AMQ13055.1) of decarboxylase (DDC) carries out codon optimization, full genome synthesizes the sequence Column, are subcloned on carrier pET28a, obtain recombinant plasmid pET28a-DDC, and the recombinant plasmid pET28a-DDC built is used Calcium Chloride Method conversion enters Bacillus coli expression host BL21(DE3), obtain DOP Adecarboxylase expression strain BL21(DE3)/ pET28a-DDC。
3. a kind of method for being catalyzed production dopamine based on DOP Adecarboxylase according to claim 1, which is characterized in that step Genetic engineering bacterium BL21(DE3 in 2)/pET28a-DDC cultural method specifically: the genetic engineering of picking expression DOP Adecarboxylase Bacterium BL21(DE3)/pET28a-DDC single colonie, be inoculated in LB culture medium, 37 DEG C of culture to OD values reach 0.6 or more, then plus Enter the IPTG of 0.5mM, 18 DEG C culture 10-12 hours, the genetic engineering bacterium BL21(DE3 of expression DOP Adecarboxylase is collected by centrifugation)/ pET28a-DDC。
4. a kind of method for being catalyzed production dopamine based on DOP Adecarboxylase according to claim 1, which is characterized in that step The final concentration amount of DOPA is 5g/l in 4, and the additive amount of phosphopyridoxal pyridoxal phosphate is 0.4mM, and the pH of reaction system is 6.8-7.0, reaction Temperature is 42 DEG C, and addition DOP Adecarboxylase crude enzyme liquid concentration is 1g/l, reaction time 1h.
5. according to right to go 1 described in it is a kind of based on DOP Adecarboxylase be catalyzed produce dopamine method, which is characterized in that step Buffer described in 4 is a kind of in phosphate buffer, PBS buffer solution or Tris- hydrochloride buffer.
6. a kind of method for being catalyzed production dopamine based on DOP Adecarboxylase according to claim 1, which is characterized in that step Reaction system is added as substrate, initial concentration 2g/l in DOPA by several times in 4, and final concentration is no more than 6g/l.
7. a kind of method for being catalyzed production dopamine based on DOP Adecarboxylase according to claim 1, which is characterized in that described The power of Ultrasonic Cell Disruptor is 300W in step 3, and shattering process is intermittent broken.
CN201910257075.0A 2019-04-01 2019-04-01 Method for producing dopamine based on catalysis of dopamine decarboxylase Pending CN109943582A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910257075.0A CN109943582A (en) 2019-04-01 2019-04-01 Method for producing dopamine based on catalysis of dopamine decarboxylase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910257075.0A CN109943582A (en) 2019-04-01 2019-04-01 Method for producing dopamine based on catalysis of dopamine decarboxylase

Publications (1)

Publication Number Publication Date
CN109943582A true CN109943582A (en) 2019-06-28

Family

ID=67013272

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910257075.0A Pending CN109943582A (en) 2019-04-01 2019-04-01 Method for producing dopamine based on catalysis of dopamine decarboxylase

Country Status (1)

Country Link
CN (1) CN109943582A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112877321A (en) * 2021-02-05 2021-06-01 南京工业大学 Method for preparing graphene immobilized enzyme and application thereof
CN112899298A (en) * 2021-03-09 2021-06-04 南京工业大学 Method for producing octopamine based on tyramine-beta-hydroxylase catalysis
CN112941002A (en) * 2021-02-08 2021-06-11 中国科学院天津工业生物技术研究所 Recombinant Escherichia coli strain for producing dopamine and construction method and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130102334A (en) * 2012-03-07 2013-09-17 한국생명공학연구원 Method for detecting dopamine and dopa decarboxylase
CN103421734A (en) * 2013-08-22 2013-12-04 江南大学 High-level soluble expression method and application of recombined tyrosine decarboxylase
CN109182320A (en) * 2018-09-05 2019-01-11 内蒙古科技大学 It is a kind of with the DOP Adecarboxylase homologue of strong catalytic activity and its preparation and application

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130102334A (en) * 2012-03-07 2013-09-17 한국생명공학연구원 Method for detecting dopamine and dopa decarboxylase
CN103421734A (en) * 2013-08-22 2013-12-04 江南大学 High-level soluble expression method and application of recombined tyrosine decarboxylase
CN109182320A (en) * 2018-09-05 2019-01-11 内蒙古科技大学 It is a kind of with the DOP Adecarboxylase homologue of strong catalytic activity and its preparation and application

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
GAO ET AL.: "Characterization and application of a recombinant dopa decarboxylase from Harmonia axyridis for the efficient biosynthesis of dopamine", 《CHINESE JOURNAL OF CHEMICAL ENGINEERING》 *
SIATERLI ET AL.: "Cloning and Expression of Human Placental L-Dopa Decarboxylase", 《NEUROCHEMICAL RESEARCH》 *
WANG ET AL.: "Tyrosine Hydroxylase and DOPA Decarboxylase Are Associated With Pupal Melanization During Larval–Pupal Transformation in Antheraea pernyi", 《FRONTIERS IN PHYSIOLOGY》 *
杨银峰等: "《生物化学与分子生物学学习指导》", 31 October 2014 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112877321A (en) * 2021-02-05 2021-06-01 南京工业大学 Method for preparing graphene immobilized enzyme and application thereof
CN112941002A (en) * 2021-02-08 2021-06-11 中国科学院天津工业生物技术研究所 Recombinant Escherichia coli strain for producing dopamine and construction method and application thereof
CN112899298A (en) * 2021-03-09 2021-06-04 南京工业大学 Method for producing octopamine based on tyramine-beta-hydroxylase catalysis

Similar Documents

Publication Publication Date Title
CN112961875B (en) A kind of construction method of engineering strain for producing tetrahydropyrimidine by biological method
WO2019157921A1 (en) Nitrilase mutant and application thereof
CN109652484B (en) A method for the efficient catalytic synthesis of L-carnosine in whole cells
CN109943582A (en) Method for producing dopamine based on catalysis of dopamine decarboxylase
CN103497911B (en) Application of Chryseobacterium sp. and carbonyl reductase thereof in production of aprepitant chiral intermediate
CN109593805B (en) A method for one-step synthesis of L-carnosine using L-amino acid ligase
US20220177868A1 (en) Nitrilase mutant and application thereof in the synthesis of an anti-epileptic drug intermediate
CN107099516B (en) 7 β -hydroxysteroid dehydrogenase mutant and application thereof in synthesis of ursodeoxycholic acid
CN111607623A (en) A method of metabolic engineering Escherichia coli to prepare α-ketoisovalerate
CN105274160B (en) A kind of method for preparing (S)-N-boc-3-hydroxypiperidine by enzymatic asymmetric reduction
CN109762768B (en) Bacillus B8W22 and its application
CN113717910B (en) Tri-enzyme co-expression recombinant bacterium and application thereof in (S) -citronellol synthesis
CN111607624A (en) A kind of method based on phenylethanolamine-N-methyltransferase catalyzed production of epinephrine
CN112143688B (en) Construction and application of recombinant escherichia coli
CN112175971A (en) Codon-optimized KRD gene and GDH gene and application thereof
CN105177078A (en) Preparation method of hydroxyectoine
CN101392225B (en) Recombinant yeast for preparing -4-chloro-3-hydroxybutanoate through asymmetric transformation and construction method and application thereof
CN113637654B (en) Recombinant phospholipase D mutant and application thereof in synthesis of phosphatidylserine
CN113481181B (en) Recombinant esterase mutant, gene, engineering bacterium and application of recombinant esterase mutant in splitting (R, S) -indoline-2-ethyl formate
CN109609536B (en) A method for whole cell one-step synthesis of L-carnosine
CN113862290A (en) A kind of isoflavone 4'-O-methyltransferase derived from licorice and its application
CN106191151B (en) A method for biotransformation and co-production of D-lysine and 5-aminovaleric acid
CN109593739B (en) Recombinant ketoacid reductase mutants, genes, engineered bacteria and their applications
CN104862264B (en) A kind of recombinant bacterium for converting production α-phenylpyruvic acid efficiency and improving
CN111733152B (en) Escherichia coli expressing inclusion body of activity of tyrosine phenol lyase and application of escherichia coli

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20190628